Wealth Plan Investment Management, LLC Sage Therapeutics, Inc. Transaction History

Wealth Plan Investment Management, LLC

  • $614 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$40.65 - $59.54 $7,398 - $10,836
182 Added 364.0%
232 $10,000
Q2 2023

Jul 25, 2023
SELL
$40.65 - $59.54 $144,998 - $212,379
-3,567 Reduced 98.62%
50 $2,000
Q1 2023

May 08, 2023
BUY
$37.27 - $46.57 $134,805 - $168,443
3,617 New
3,617 $151,000

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
48.2M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $395M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Wealth Plan Investment Management, LLC Portfolio

Follow Wealth Plan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email